General
Preferred name
ALUMINUM HYDROXIDE
Synonyms
algeldrate ()
Aluminic hydroxide, Aluminum trihydroxide, Aluminium(III) hydroxide ()
ALMAGATE ()
Sarpep ()
Aludrox ()
NSC-664400 ()
Dried aluminum hydroxide gel ()
Aluminium hydroxide ()
Aluminium hydroxide gel, dried ()
Aluminum hydroxide component of gaviscon ()
Alu-Cap ()
Almax ()
LAS 3876 ()
LAS-3876 ()
Almagato ()
P&D ID
PD009244
CAS
21645-51-2
66827-12-1
Tags
drug candidate
inorganic
drug
available
Approved by
FDA
First approval
1983
Drug Status
approved
investigational
Max Phase
2.0
4.0
Drug indication
severe acute respiratory syndrome
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Aluminum Hydroxide is an orally active primary form of aluminum used as an adjuvant. Research on aluminum hydroxide-based adjuvants includes examining its repository effect, pro-phagocytic effect, and activation of the pro-inflammatory NLRP3 pathway.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
8
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
44
Molecular Weight
77.99
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
3
Rotatable Bonds
0
Ring Count
0
Aromatic Ring Count
0
cLogP
-2.05
TPSA
60.69
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
0.0
QED
0.29
QED
0.29
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
NOD-like Receptor (NLR)
Pathway
Immunology/Inflammation
Source data
